Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. de Miquel
Abediterol (LAS100977), a Novel Long-Acting Β2-Agonist: Efficacy, Safety and Tolerability in Persistent Asthma
Respiratory Medicine
Pulmonary
Respiratory Medicine
Related publications
Long-Acting 2-Agonists in Asthma: Safety Concerns
CMAJ
Medicine
Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Comparison With Other Long-Acting Muscarinic Antagonist/Long-Acting Β2-Agonist Fixed-Dose Combinations in COPD
Therapeutic Advances in Respiratory Disease
Pulmonary
Respiratory Medicine
Pharmacology
Changing Patterns of Asthma Medication Use Related to US Food and Drug Administration Long-Acting Β2-Agonist Regulation From 2005-2011
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Insulin Toujeo® — A Novel Basal Long-Acting Insulin Formulation. Part 2. Clinical Efficacy and Safety
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
Potential Masking Effect on Dyspnoea Perception by Short- And Long-Acting Β2-Agonists in Asthma
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Comparison of Vilanterol, a Novel Long-Acting Beta2 Agonist, With Placebo and a Salmeterol Reference Arm in Asthma Uncontrolled by Inhaled Corticosteroids
Journal of Negative Results in BioMedicine
Genetics
Pharmacology
Molecular Biology
Biochemistry
Medicine
Toxicology
Pharmaceutics
Long-Term Efficacy and Safety of Omalizumab in Patients With Persistent Uncontrolled Allergic Asthma: A Systematic Review and Meta-Analysis
Scientific Reports
Multidisciplinary
Long-Acting Β-Agonist Prescribing in People With Asthma in Primary Care: Table 1
Thorax
Pulmonary
Respiratory Medicine
Do Long-Acting Β2-Adrenoceptor Agonists Enhance the Anti-Inflammatory Effect of Glucocorticoids in Asthma?
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
